CLASS ACTION NOTICE: Berger Montague Advises Zynex (NASDAQ: ZYXI) Investors to Inquire About a Securities Fraud Class Action

Core Viewpoint - A securities class action lawsuit has been filed against Zynex, Inc. for allegedly misleading investors regarding its revenue practices and product shipments during the class period from March 13, 2023, to March 11, 2025 [1][3]. Group 1: Lawsuit Details - The lawsuit claims that Zynex shipped products, including electrodes, in excess of demand, which allowed the company to inflate its revenue [3]. - It is alleged that Zynex's practice of filing false claims attracted scrutiny from insurers, including Tricare, leading to potential adverse consequences such as removal from insurer networks and federal penalties [3]. Group 2: Company Information - Zynex, headquartered in Englewood, CO, specializes in manufacturing electrotherapy devices for pain management and rehabilitation [2]. - Investors who purchased Zynex securities during the class period have until May 19, 2025, to seek appointment as lead plaintiff representatives [2].